TrialCPT: pharmacometrics & systems pharmacology2022

Population pharmacokinetic-pharmacodynamic modeling of PB2452, a monoclonal antibody fragment being developed as a ticagrelor reversal agent, in healthy volunteers.

Steven J Kathman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.